BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27590365)

  • 1. Uterine sarcoma Part I-Uterine leiomyosarcoma: The Topic Advisory Group systematic review.
    Wen KC; Horng HC; Wang PH; Chen YJ; Yen MS; Ng HT;
    Taiwan J Obstet Gynecol; 2016 Aug; 55(4):463-71. PubMed ID: 27590365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma.
    Giuntoli RL; Lessard-Anderson CR; Gerardi MA; Kushnir CL; Cliby WA; Metzinger DS; Gostout BS
    Int J Gynecol Cancer; 2013 Jun; 23(5):869-76. PubMed ID: 23669444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging of uterine sarcomas.
    Tse KY; Crawford R; Ngan HY
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey.
    Durnali A; Tokluoğlu S; Özdemir N; Inanç M; Alkiş N; Zengin N; Sönmez ÖU; Küçüköner M;
    Asian Pac J Cancer Prev; 2012; 13(5):1935-41. PubMed ID: 22901150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
    D'Angelo E; Spagnoli LG; Prat J
    Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine sarcomas.
    Mbatani N; Olawaiye AB; Prat J
    Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myxoid leiomyosarcoma of the uterus: a clinicopathological and immunohistochemical study of 10 cases.
    Lu B; Shi H; Zhang X
    Hum Pathol; 2017 Jan; 59():139-146. PubMed ID: 27717885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine sarcomas: clinical presentation and MRI features.
    Santos P; Cunha TM
    Diagn Interv Radiol; 2015; 21(1):4-9. PubMed ID: 25347940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine sarcoma part III-Targeted therapy: The Taiwan Association of Gynecology (TAG) systematic review.
    Yen MS; Chen JR; Wang PH; Wen KC; Chen YJ; Ng HT;
    Taiwan J Obstet Gynecol; 2016 Oct; 55(5):625-634. PubMed ID: 27751406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the treatment of sarcomas in gynecology.
    Lange SS; Novetsky AP; Powell MA
    Discov Med; 2014 Sep; 18(98):133-40. PubMed ID: 25227754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic treatment in adult uterine sarcomas.
    Desar IME; Ottevanger PB; Benson C; van der Graaf WTA
    Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine leiomyosarcoma.
    Hannigan EV; Gomez LG
    Am J Obstet Gynecol; 1979 Jul; 134(5):557-64. PubMed ID: 453295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gynecologic Cancer InterGroup (GCIG) consensus review for high-grade undifferentiated sarcomas of the uterus.
    Pautier P; Nam EJ; Provencher DM; Hamilton AL; Mangili G; Siddiqui NA; Westermann AM; Reed NS; Harter P; Ray-Coquard I
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S73-7. PubMed ID: 25341584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathologic characteristics and prognosis factors of uterine sarcomas in central Tunisia].
    Khlifi A; Fathallah K; Zbidi C; Hidar S; Bibi M; Khairi H
    Bull Cancer; 2014; 101(7-8):669-80. PubMed ID: 25091649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome and prognosis in uterine sarcoma and malignant mixed Mullerian tumor.
    Burghaus S; Halmen S; Gass P; Mehlhorn G; Schrauder MG; Lux MP; Renner SP; Beckmann MW; Hein A; Thiel FC
    Arch Gynecol Obstet; 2016 Aug; 294(2):343-51. PubMed ID: 26711836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uterine sarcoma in Tunisia: retrospective study about 14 cases].
    Bouzid N; Kanoun Belajouza S; Boussen H; Bouaouina N
    Gynecol Obstet Fertil; 2014 Dec; 42(12):838-43. PubMed ID: 25155830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uterine sarcoma: a clinicopathological study of 93 cases.
    González-Bosquet E; Martínez-Palones JM; González-Bosquet J; García Jiménez A; Xercavins J
    Eur J Gynaecol Oncol; 1997; 18(3):192-5. PubMed ID: 9174834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence.
    Goff BA; Rice LW; Fleischhacker D; Muntz HG; Falkenberry SS; Nikrui N; Fuller AF
    Gynecol Oncol; 1993 Jul; 50(1):105-9. PubMed ID: 8349151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.